Abstract
The new reality imposed by the coronavirus pandemic implies the reinvention of ways to do scientific research and follow up on chronic diseases. Among chronic diseases in the pediatric age group, asthma stands out. With a prevalence of around 20% in pediatrics, causing an important individual and collective impact, regular follow-up becomes a fundamental basis for treatment. In this conte…